These results suggest that miR-27a-3p upregulation may serve as a diagnostic marker for cardiac hypertrophy, and miR-27a-3p upregulation promotes cardiac hypertrophy by targeting NOVA1. Here, NOVA1 is linked to cardiac hypertrophy.